🕺 🏃 🩺
Muvalaplin reduced lipoprotein(a) measured using intact lipoprotein(a) and apolipoprotein(a)-based assays and was well tolerated.
https://ja.ma/4g7qutR
Dr. Philippe BARTHÉLÉMY
Looking ahead: RCC management in 2025
Importance of precision medicine, optimization of combination therapies & need for new biomarkers to improve outcomes.
#KidneyCancer
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
Dr. Philippe BARTHÉLÉMY
Looking ahead: RCC management in 2025
Importance of precision medicine, optimization of combination therapies & need for new biomarkers to improve outcomes.
#KidneyCancer
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social